This antibody was purified from hybridoma (clone 17A10) supernatant using protein A agarose. This hybridoma was established by fusion of mouse myeloma cell Sp2/0 with C57BL/6 Tg mouse splenocyte immunized with the recombinant human HLA-A24.
Target:
HLA-A24
Application Dilute:
FCM: 10 µg/mL (final concentration)
* VAT and and shipping costs not included. Errors and price changes excepted